Search filters

List of works by Cristina Gervasoni

ACE inhibitors and ribavirin-associated cough: a common undefined predisposing factor?

scientific article published on 19 September 2012

Assessment of Antiepileptic Drug Concentrations in HIV-Infected versus HIV-Negative Patients: A Retrospective Analysis

scientific article published on 01 October 2019

Association of HIV Infection with Epilepsy and Other Comorbid Conditions

scientific article published on 01 April 2020

Bictegravir/emtricitabine/tenofovir alafenamide-induced acute pancreatitis: a case report

scientific article published on 21 July 2020

Burden of Exposure to Potential Interactions Between Antiretroviral and Non-Antiretroviral Medications in a Population of HIV-Positive Patients Aged 50 Years or Older

scientific article published on 01 June 2018

Clinical features and outcomes of HIV patients with coronavirus disease 2019

scientific article published on 14 May 2020

Co-administration of raltegravir reduces daily darunavir exposure in HIV-1 infected patients

scientific article published on 20 September 2011

Comparison of the In Vivo Pharmacokinetics and In Vitro Dissolution of Branded Versus Generic Efavirenz Formulation in HIV-Infected Patients

scientific article

Comparison of the in vivo pharmacokinetics and in vitro dissolution of raltegravir in HIV patients receiving the drug by swallowing or by chewing

scientific article

Comparison of the pharmacokinetics of raltegravir given at 2 doses of 400 mg by swallowing versus one dose of 800 mg by chewing in healthy volunteers: a randomized, open-label, 2-period, single-dose, crossover phase 1 study

scientific article published on February 2015

Determinants of bone diseases in tenofovir-treated HIV patients.

scientific article published on June 2016

Different effects of glucocorticoids on darunavir plasma concentrations

scientific article published on 09 January 2019

Dolutegravir plasma concentrations according to companion antiretroviral drug: unwanted drug interaction or desirable boosting effect?

scientific article published on 23 December 2016

Drug-Drug Interactions and Prescription Appropriateness in Patients with COVID-19: A Retrospective Analysis from a Reference Hospital in Northern Italy

scientific article published on 05 November 2020

Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS-CoV-2 infection: a retrospective cohort study

scientific article published on 10 August 2020

Effect of cobicistat on tenofovir disoproxil fumarate (TDF): what is true for TAF may also be true for TDF.

scientific article published on 25 September 2017

Effects of ritonavir and cobicistat on dolutegravir exposure: when the booster can make the difference

scientific article published on 3 March 2017

Effects of ursodeoxycholic acid on rilpivirine plasma trough concentrations: a case report

scientific article published on 03 January 2020

Evaluation of the concentrations of psychotropic drugs in HIV-infected versus HIV-negative patients: Potential implications for clinical practice

article

How Relevant is the Interaction Between Dolutegravir and Metformin in Real Life?

scientific article published on 20 January 2017

Immune deficiency is a risk factor for severe COVID-19 in people living with HIV

scientific article published on 27 December 2020

Impact of Therapeutic Drug Monitoring of Antiretroviral Drugs in Routine Clinical Management of People Living With HIV: A Narrative Review

scientific article published on 01 February 2020

Incidence of adipose tissue alterations in first-line antiretroviral therapy: the LipoICoNa Study

scientific article published on December 2002

Inter- and intra-patient variability of raltegravir pharmacokinetics in HIV-1-infected subjects

scientific article published on 29 November 2011

Is it time to revise linezolid doses in peritoneal dialysis patients? A case series.

scientific article published on 3 July 2015

Is there still room for therapeutic drug monitoring of linezolid in patients with tuberculosis?

scientific article published on 01 April 2016

Less drug regimens and PI/r-based strategies in HIV infection: focus on best practices using the HIV patient's journey methodology

scientific article published on April 2014

Levofloxacin-induced seizures in a patient without predisposing risk factors: the impact of pharmacogenetics

scientific article published on 25 April 2013

Limited sampling strategies for the estimation of raltegravir daily exposure in HIV-infected patients.

scientific article published on 7 March 2011

Linezolid-related haematological toxicity in a peritoneal dialysis patient: the role of therapeutic drug monitoring

scientific article published on 22 January 2015

Liver Injury After Occasional Energy Drink Use in a Patient Living With HIV and Diabetes

scientific article published on 18 October 2019

Lopinavir/ritonavir in COVID-19 patients: maybe yes, but at what dose?

scientific article published on 14 May 2020

Loss of Control of HIV Viremia With OTC Weight-Loss Drugs: A Call for Caution?

scientific article published on 01 August 2018

Low body weight in females is a risk factor for increased tenofovir exposure and drug-related adverse events

scientific article (publication date: 2013)

Metabolic and kidney disorders correlate with high atazanavir concentrations in HIV-infected patients: is it time to revise atazanavir dosages?

scientific article

Multidrug-resistant HIV viral rebound during early syphilis: a case report

scientific article published on 07 April 2020

Orlistat: weight lost at cost of HIV rebound

scientific article published on 5 March 2016

Pharmacogenetics-based optimisation of atazanavir treatment: potential role of new genetic predictors.

scientific article published in May 2017

Potential association between rosuvastatin use and high atazanavir trough concentrations in ritonavir-treated HIV-infected patients

scientific article published on 3 October 2014

Prolonged inductive effect of rifampicin on linezolid exposure

scientific article published on 18 March 2015

Reduced raltegravir clearance in HIV-infected liver transplant recipients: an unexpected interaction with immunosuppressive therapy?

scientific article

Relapse of Kaposi's Sarcoma and HHV-8 viremia in an HIV-infected patient switching from protease inhibitor to integrase inhibitor-based antiretroviral therapy

scientific article published on 2 December 2015

Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study

scientific article published on 26 March 2020

Severe Hyperbilirubinemia in an HIV-HCV-Coinfected Patient Starting the 3D Regimen That Resolved After TDM-Guided Atazanavir Dose Reduction

scientific article

Suspected pharmacokinetic interaction between raltegravir and the 3D regimen of ombitasvir, dasabuvir and paritaprevir/ritonavir in an HIV-HCV liver transplant recipient.

scientific article

Switching to unboosted atazanavir reduces bilirubin and triglycerides without compromising treatment efficacy in UGT1A1*28 polymorphism carriers

scientific article published on 02 June 2012

The Less Drugs Regimens (LDRs) therapy approach in HIV-1: an Italian expert panel perspective for the long-term management of HIV-1 infection

scientific article published on June 30, 2012

Therapeutic drug management of linezolid: a missed opportunity for clinicians?

scientific article

When food can make the difference: The case of elvitegravir-based co-formulation

scientific article published on 31 August 2016

Paulina is supported by:

About Paulina

Help